Trial Search Results
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Procedure: Stereotactic radiosurgery
Phase:
Phase 1/Phase 2
Eligibility
Inclusion Criteria:- Intra-axial, extra-axial, or vertebral spinal lesion
- Age > 5
- Histologic confirmation of malignant primary lesion or radiographic diagnosis of
benign or vascular spinal lesion
- No rapidly deteriorating symptoms of spinal cord compression
- No instability of the spine
- Life expectancy > 6 months Exclusion Criteria:- Patients without tumors of the spine
- Patients younger than 5 years old
Ages Eligible for Study
5 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Laurie Tupper
6507361694